✦ LIBER ✦

Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: Study design and preliminary safety results

✍ Scribed by Thierry André; Philippe Colin; Christophe Louvet; Erick Gamelin; Olivier Bouche; Emmanuel Achille; Nicolas Colbert; Catherine Boaziz; Pascal Piedbois; Nicole Tubiana-Mathieu; Arnaud Boutan-Laroze; Michel Flesch; Véronique Billiau; Marc Buyse

Book ID: 114105414
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 622 KB
Volume: 28
Category: Article
ISSN: 0093-7754
DOI: 10.1016/s0093-7754(01)90250-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant chemotherapy with oxaliplatin,

Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer: Abstracted from: André T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343–51

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 213 KB